Two weeks ago I wrote here about a study by the La Jolla Institute for Immunology in California, which found that between 40 and 60 per cent of people who had never been exposed to SARS-CoV-2 – the virus which causes Covid 19 – nevertheless seemed to develop an immune response to the disease in their T Cells. They appeared to have a cross-reactive immunity which had been gained through exposure to other coronaviruses – those which cause the common cold.
Now comes another study providing more evidence of the same phenomenon from a team at the Emerging Infectious Diseases Program from Duke-NUS Medical School in Singapore. Nine of 18 patients they studied showed an immune reaction in their T cells to a protein in SARS-CoV-2, in spite of never having been exposed to the virus.
The team also found that survivors of SARS – the novel coronavirus disease which had an outbreak in 2002/03 and then largely disappeared – possess a ‘robust’ cross-reactive immune response to SARS-CoV-2.
The usual caveats apply. This is a study yet to be peer-reviewed and it involved only a small number of individuals, but it does raise interesting questions over Covid-19. There has been a widespread assumption that no-one has any immunity to SARS-CoV-2, and that unless suppressed by social distancing or by a vaccine it will go on to infect the majority of the population. The government’s response to Covid-19, as well as the Imperial College modelling which has proved so influential on it, has worked on the assumption that 80 per cent of the population could go on to become infected. But if some of the population have a degree of resistance thanks to previous infection with other coronaviruses then the numbers change.
Already a subscriber? Log in
Comments
Don't miss out
Join the conversation with other Spectator readers. Subscribe to leave a comment.
UNLOCK ACCESSAlready a subscriber? Log in